AI Demand Is Coming—Is Microchip Technology Ready?

Microchip Technology (MCHP) reported Q2 revenue of $1.14 billion, a 1.7% year-over-year decline, but exceeded EPS estimates with $0.35, driven by strength in North America, Asia, and AI/data center segments. Despite the company's strong positioning for long-term AI demand, including new products like the Gen 6 PCIe switch, tepid FQ3 guidance led to an initial stock drop of over 8% and analyst price target reductions. Management, however, expects growth to resume in FQ3 and accelerate significantly into FY2026/2027, with a robust earnings forecast for FY2027, suggesting a potential rebound once institutional accumulation, currently a near-term headwind, resumes, likely in early to mid-2026.

Analysis

Microchip Technology (MCHP) reported Q2 net revenue of $1.14 billion, a modest 1.7% year-over-year decline, yet adjusted EPS of $0.35 surpassed consensus estimates by two cents. This performance was driven by sequential growth in North America and Asia, alongside strong contributions from data centers and AI. The company is strategically positioned for long-term AI demand, evidenced by new product launches like the Gen 6 PCIe switch, with commercial scale expected by mid-2026.

Despite solid Q2 results, MCHP's conservative FQ3 guidance fell short of consensus expectations, leading to a "mildly negative" market sentiment and an initial stock drop exceeding 8%. Analysts consequently lowered price targets, creating near-term headwinds. However, management projects growth to resume in FQ3 and accelerate significantly into FY2026 and FY2027, with over 75% earnings growth forecast for FY2027.

Institutional investors, holding over 90% of shares, sold on balance in October, contributing to the stock's pressure. A rebound is contingent on a shift back to institutional accumulation, likely signaled by price action. While the dividend yields over 3%, its current payout exceeds FY2026 earnings; however, a strong balance sheet and robust FY2027 earnings forecast mitigate this risk. A potent catalyst for recovery may not emerge until early to mid-2026, absent broader economic improvements.

Key Decisions for Investors

• Monitor institutional activity for signs of accumulation, as this will likely signal a shift in market sentiment and potential stock recovery.
• Evaluate MCHP's long-term AI positioning and FY2026/2027 growth projections against near-term guidance conservatism and current dividend sustainability.
• Consider the stock's current valuation relative to the 25% upside indicated by consensus estimates, acknowledging potential catalysts may be delayed until mid-2026.